↓ Skip to main content

Low-dose nivolumab in advanced hepatocellular carcinoma

Overview of attention for article published in BMC Cancer, November 2022
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (86th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

twitter
15 X users

Citations

dimensions_citation
5 Dimensions

Readers on

mendeley
15 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Low-dose nivolumab in advanced hepatocellular carcinoma
Published in
BMC Cancer, November 2022
DOI 10.1186/s12885-022-10271-6
Pubmed ID
Authors

Yen-Hao Chen, Chih-Chi Wang, Yen-Yang Chen, Jing-Houng Wang, Chao-Hung Hung, Yuan-Hung Kuo

X Demographics

X Demographics

The data shown below were collected from the profiles of 15 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 15 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 15 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 3 20%
Researcher 3 20%
Student > Bachelor 2 13%
Student > Ph. D. Student 1 7%
Lecturer 1 7%
Other 0 0%
Unknown 5 33%
Readers by discipline Count As %
Unspecified 3 20%
Biochemistry, Genetics and Molecular Biology 2 13%
Nursing and Health Professions 1 7%
Social Sciences 1 7%
Medicine and Dentistry 1 7%
Other 1 7%
Unknown 6 40%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 February 2023.
All research outputs
#2,947,563
of 24,247,965 outputs
Outputs from BMC Cancer
#601
of 8,612 outputs
Outputs of similar age
#59,901
of 431,546 outputs
Outputs of similar age from BMC Cancer
#2
of 204 outputs
Altmetric has tracked 24,247,965 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,612 research outputs from this source. They receive a mean Attention Score of 4.5. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 431,546 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 86% of its contemporaries.
We're also able to compare this research output to 204 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.